As parents clamor for a treatment touted for autism, doctors hesitate to prescribe it After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust. Michal Ruprecht
GLP-1 drugs like Ozempic can curb addiction risk, study finds A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. Jon Hamilton
A new single-pill treatment for HIV shows promising results A new single-pill treatment for HIV has shown promising results. This is particularly useful for people who have had HIV for decades. Gabrielle Emanuel
He suffered two strokes. This electric brain implant helped him regain use of his arm Perhaps the most compelling finding from a UW Medicine study to help stroke victims recover hand movement is that if its first subject applied to be part of the study today, he would not qualify. Stephen Howie
FDA reverses decades of guidance on hormone therapy for menopause NPR's Juana Summers talks to FDA Commissioner Martin Makary about the administration's decision to remove the black box warning label on hormone replacement therapy. Juana Summers
CRISPR gene-editing works to reduce high cholesterol in a new study An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, possibly helping cut the risk for heart disease. Rob Stein
This 4-year-old's heart is failing. A federal grant that might help him was canceled A Cornell University researcher has been developing an artificial heart for children for more than 20 years. Now, his research is on hold and his lab is shut down. Elissa Nadworny
What to know about getting an updated COVID-19 vaccine Now that the CDC has finally issued final guidelines for the updated COVID-19 vaccines, at least some of the confusion on eligibility should clear up. Rob Stein
A surprising new treatment for rheumatoid arthritis The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis. Jon Hamilton
RFK Jr.'s vaccine panel is expected to recommend delaying hepatitis B shot in kids A vaccine advisory panel, recently reshaped by RFK Jr., is expected to vote on changing the age children should get their first hepatitis B vaccine -- from right after birth to age 4. Jackie Fortiér